Phase 1 Study of URC102 in Healthy Subjects

Summary

To assess the safety, tolerability, PK and PD of URC102 in healthy subjects. To evaluate the food effect on PK.

Timeline

Start

2013-05-23

Primary completion

2013-12-24

Completion

2014-07

Publications

• Lee HA, Yu KS, Park SI, Yoon S, Onohara M, Ahn Y, Lee H. URC102, a potent and selective inhibitor of hURAT1, reduced serum uric acid in healthy volunteers. Rheumatology (Oxford). 2019 Nov 1;58(11):1976-1984. doi: 10.1093/rheumatology/kez140.

Drugs

Indications

No indication recorded.